Well, since the release of positive data from this late-stage study ... this would be the ongoing development and proof-of-concept from its fifth pherine drug known as PH284.

The detailed terms of the license have not been disclosed but Avacta would receive development milestone payments and royalties on sales of an approved drug developed by Glythera. The antibody drug ...

DeepLife has deployed and established proof-of-concept for its platform ... to validate the use of digital twins in drug discovery, setting the stage for more widespread adoption of this ...

“Our proprietary intranasal platform has the potential to enhance drug delivery bioavailability. We believe that intranasal delivery has the potential to improve patient outcomes by providing a ...

“Each strain is selected for its functionality, via a defined mechanism of action, in a targeted drug ... rapid development of LBPs, 4D moved from discovery to first-in-class proof-of-concept ...

Gilead and Novo Nordisk have announced their drug combinations for the fatty liver disease known as NASH checked out in a mid-stage proof-of-concept study. The companies said the trial met its ...

Synthetic biology specialist Synlogic will start phase 3 testing of a drug for rare metabolic disorder phenylketonuria (PKU) next year, after reporting solid proof-of-concept data. PKU is a rare ...

Jaguar expects first results in Q2 2025 of proof-of-concept investigator ... the U.S. Food and Drug Administration's (FDA) Breakthrough Therapies program. If a drug is designated as breakthrough ...